Search the Community
Showing results for tags 'pfizer'.
Found 5 results
-
https://www.instagram.com/reel/CtQ6J7wAqoO/?igshid=NzgyYTk0Y2YyNg%3D%3D
- 1 reply
-
- 2
-
-
- pfizer
- anderson cooper
- (and 1 more)
-
Pfizer (+0.75%) is putting its consumer healthcare business on the trading block, either as a sale or spin-off. The drugmaker’s $3.4 billion unit features a medicine cabinet of popular productsyou’ll probably use at least once today, such as ChapStick, Centrum, and Advil. So what’s got Pfizer thinking about drug deals? Well, the $10 billion+ from a sale would give it ammo for a blockbuster acquisition(rumor on the street…it’s eyeing BMS). Plus, Pfizer is looking to zero in on its lucrative prescription drug business that has helped boost shares 7.5% YoY. This might be déjà vu all over again for Pfizer. It sold its consumer healthcare business to J&J back in 2006 for $16.6 billion only to buy another portfolio (which included Advil and ChapStick) when it acquired Wyeth in 2009. So why not write a script for one more? https://www.morningbrew.com/stories/doctors-orders/
-
-
"We have a good chance that we will know if the product works by the end of October"—Pfizer CEO Albert Bourla discussing his company's potential coronavirus vaccine. Bourla thinks regulators could approve the drug before 2021. https://thehill.com/policy/healthcare/516194-pfizer-ceo-preparing-for-likelihood-of-vaccine-approval-before-end-of-year -
https://www.bloomberg.com/news/articles/2020-07-22/pfizer-biontech-receive-u-s-order-for-covid-vaccine?utm_campaign=socialflow-organic&utm_medium=social&utm_content=business&utm_source=twitter&cmpid=socialflow-twitter-business In signing a $2 billion deal to supply their experimental coronavirus vaccine to the U.S., Pfizer Inc.and BioNTech SE are setting a price ceiling of less than $20 a dose that will impact how much other companies can charge to protect people from Covid-19. Interestingly, the CEO went into this saying that this wouldn’t be a profitable endeavor, but they’re pushing forward anyway.
